GLN-GABAPENTIN
Identification of Gln-Gabapentin
| No description |
Google image searchProduct monograph
Active ingredient
gabapentin, 800 MG
DIN: 02411008
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: GLENMARK PHARMACEUTICALS CANADA INC.
Date: 29-MAY-2019
ATC:
- N02 — ANALGESICS (ATC, ATC/DDD, )
- N02B — OTHER ANALGESICS AND ANTIPYRETICS (ATC, ATC/DDD)
- N02BF — Gabapentinoids (ATC, ATC/DDD)
- N02BF01 — GABAPENTIN (ATC/DDD)
Reference brand drug: Neurontin
Pharmaceutical standard: USP
